🎤 Join our founder group to hear from firms like NEA on What it takes to raise a Series A?

Register
Joshua (Josh) Resnick, MD

Joshua (Josh) Resnick, MD

Partner·RA Capital Management

Boston, Massachusetts

Bio

Professional summary

Josh Resnick is a Partner at RA Capital Management, where his official profile says he leads early-stage private investments and oversees the creation of new companies developing drugs, medical devices, diagnostics, and research tools. He has more than 15 years of experience across investing, company formation, company leadership, and drug development stages from discovery through commercialization. Before RA Capital, he was co-lead of SV Health Investors’ US Biotech practice, President and Managing Partner at MRL Ventures Fund, a Venture Partner at Atlas Venture, and a Partner at Prism Venture Partners. He is also listed as a Harvard Medical School faculty member and an attending physician in Emergency Medicine at Massachusetts General Hospital. He holds a BA in Chemistry from Williams College, an MD from the University of Pennsylvania School of Medicine, and an MBA from Wharton.

Investment focus

Stage, sector, and overall fit

Stage

company formationseedSeries Aearly-stage private healthcare

Sector

biotechnologylife sciencestherapeuticsmedical devicesdiagnosticsresearch tools

Thesis

Early-stage private healthcare investmentsNew company creation in drugs, medical devices, diagnostics, and research toolsTherapeutics-focused venture creation

Notable companies

Selected portfolio companies the partner has backed

Brahma DiscoveryMRL Ventures Fund

How to approach

Framing and angles for outreach

Pitch framing

Strong fit for founder outreach around early-stage healthcare company creation, especially therapeutics or platform ideas needing venture-building support.

Personalization hooks

  1. 1Reference his hands-on company formation background across SV Health Investors, MRL Ventures, Atlas Venture, and Prism.
  2. 2For clinically relevant products, mention his continued emergency medicine and Harvard Medical School connection.

Background

Career, education, and skills

Career history

  • RA Capital ManagementPartner2018–present
  • Raven (RA Capital Incubator)Co-Founder & Presidentongoing
  • Massachusetts General HospitalAttending Physician, Emergency Medicine2015–present
  • Synolo TherapeuticsCo-Founder
  • Stylus MedicineCo-Founder

Education

  • University of Pennsylvania, Perelman School of MedicineMD2002
  • The Wharton School, University of PennsylvaniaMBA2002

Skills

biopharmaceutical investmentcompany incubationemergency medicinedrug discoveryclinical development

Other partners at RA Capital Management

12 more profiles

Abigail (Lauterbach) Schmitz

Abigail (Lauterbach) Schmitz

Senior Associate

RA Capital Management

TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.

biotech diligencecompetitive landscapesportfolio strategyTechAtlastherapeutics
Adam Prince, MD

Adam Prince, MD

Senior Associate, Strategic Initiatives

RA Capital Management

RA Capital TechAtlas senior associate with cardiology and medical training.

biotech diligencecardiologyhealth innovationportfolio strategyTechAtlas
Alana MacDonald, Ph.D.

Alana MacDonald, Ph.D.

Senior Associate

RA Capital Management

Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.

biotechnologycompetitive landscapesportfolio strategyTechAtlastherapeutics
Alejandro Sevilla

Alejandro Sevilla

Associate

RA Capital Management

Planetary Health associate focused on climate-tech landscapes and investment evaluation.

advanced batteriesclimate technologycompetitive landscapesenergy storageplanetary health
Alex Miller

Alex Miller

Senior Associate, Venture

RA Capital Management

Venture senior associate focused on biotech diligence and portfolio strategy.

biotechnologyprogram strategyTechAtlastherapeuticsventure investing
Alex T. Zhang

Alex T. Zhang

Vice President, Structured Capital

RA Capital Management

Structured Capital VP focused on healthcare and life-sciences credit investments.

commercial-stage healthcarehealthcare creditlife sciencesprivate creditstructured capital
Alexander Martinez-Forte

Alexander Martinez-Forte

Director, Quantitative Research & Strategy

RA Capital Management

RA Capital director leading quantitative analyses for investment decisions and portfolio management.

Data scienceFinancial riskHealthcare investingInvestment analyticsPortfolio managementQuantitative research
Allison Harrigan

Allison Harrigan

Senior Director Corporate Development

RA Capital Management

Raven corporate development leader focused on biotech company creation.

Biotech strategyBusiness developmentCompany creationCorporate developmentDrug discovery
Alyssa Larson

Alyssa Larson

Director, Healthcare Specialist - Investor Relations

RA Capital Management

TechAtlas director supporting healthcare diligence and investor relations.

BiochemistryCompetitive landscapesHealthcare diligenceInvestor relationsTechAtlas
Ami Thakrar, PhD

Ami Thakrar, PhD

Associate

RA Capital Management

TechAtlas associate focused on biotech diligence and program strategy.

biotechnologycompetitive landscapesmedical engineeringprogram strategyTechAtlas
Anish K. More

Anish K. More

Vice President, Corporate Development

RA Capital Management

Raven corporate-development VP focused on investment evaluation and NewCo creation.

company creationcorporate developmenthealthcare servicesNewCosRaven
Anurag Kondapalli

Anurag Kondapalli

Principal

RA Capital Management

Principal investing across public and private healthcare technology and services companies.

healthcare serviceshealthcare technologyprivate investmentspublic investmentsstructured growth capital